Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes; we will fulfill your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C. Lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its incorporation.
KEGG: efa:EF1404
STRING: 226185.EF1404
MutS2 in E. faecalis, like its homologs in other bacterial species, plays crucial roles in DNA recombination and repair processes . While traditional MutS1-family proteins primarily function in DNA mismatch repair (MMR), MutS2 proteins have evolved distinct functions . Based on comparative studies with other bacterial MutS2 proteins, E. faecalis MutS2 likely contributes to:
Regulation of homologous recombination events
Protection against foreign DNA through nuclease activity
Maintenance of genomic integrity during stress conditions
Recent findings in Bacillus subtilis suggest MutS2 may also function in ribosome quality control by resolving stalled translation complexes, splitting them into subunits . This indicates MutS2 may have broader roles in cellular stress responses beyond DNA metabolism.
Methodologically, researchers investigating MutS2 function should consider both genetic approaches (targeted gene disruption) and biochemical characterization of the purified protein to fully elucidate its roles in E. faecalis.
E. faecalis MutS2 differs from MutS1-family proteins and shows specific structural characteristics:
| Domain | Function in MutS2 | Comparison to MutS1 |
|---|---|---|
| N-terminal | ATPase activity (Walker motifs) | Present in both families but with sequence variations |
| Middle region | DNA binding | Lacks mismatch recognition domain found in MutS1 |
| C-terminal | SMR (Small MutS-Related) domain with nuclease activity | Absent in MutS1; distinctive to MutS2 family |
| KOW domain | Potential ribosome interaction | Not present in MutS1 proteins |
The most distinctive structural feature of MutS2 is the presence of the SMR domain, which confers nuclease activity absent in MutS1 proteins . Based on structural studies of B. subtilis MutS2, the SMR domain appears to be crucial for recognizing and resolving stalled ribosomes, suggesting a potential similar role in E. faecalis .
Researchers should note that while E. faecalis MutS2 shares domain architecture with other bacterial MutS2 proteins, species-specific variations may exist that influence substrate specificity and regulation.
Based on successful approaches with other bacterial MutS2 proteins, the following expression systems can be considered:
E. coli-based expression systems:
BL21(DE3) strain with pET-based vectors offers high-yield expression
Arctic Express strains may improve folding at lower temperatures
Codon optimization is recommended as E. faecalis uses a different codon bias than E. coli
Protein solubility considerations:
Purification strategy:
Sequential chromatography combining affinity (His-tag), ion exchange, and size exclusion
Typical yield: 2-5 mg of purified protein per liter of culture
When validating expression, researchers should confirm proper folding using circular dichroism and functional assays for ATPase and nuclease activities. For structural studies requiring native protein, consider FLAG-tagged constructs expressed in B. subtilis as an alternative model, as demonstrated in previous studies .
E. faecalis is both a commensal and an opportunistic pathogen responsible for various infections, including surgical site infections and diabetic ulcers . To investigate MutS2's potential role in pathogenicity:
Construction of mutS2 knockout strains:
Comparative virulence studies:
Infection models (C. elegans, G. mellonella, murine models)
Biofilm formation assays (crystal violet staining, confocal microscopy)
Immune evasion assessments (macrophage and neutrophil interaction studies)
Transcriptomic analysis:
Compare wild-type and ΔmutS2 strains during infection using RNA-seq
Focus on genes involved in virulence factor expression, stress responses, and antibiotic resistance
E. faecalis has mechanisms to evade and suppress immune clearance, including suppression of pro-inflammatory responses and prevention of neutrophil extracellular trap formation . Researchers should examine whether MutS2 influences these immune evasion processes, particularly given the potential role of MutS2 in stress responses.
Based on recent findings in B. subtilis MutS2, which revealed a novel role in ribosome rescue , researchers investigating similar functions in E. faecalis MutS2 should consider:
Structural approaches:
Biochemical validation:
In vivo functional studies:
Data analysis approach:
Quantify truncated protein products by western blotting
Compare wild-type and mutant MutS2 effects on ribosome collision resolution
Assess polysome profiles with and without collision-inducing treatments
| Domain Mutation | Expected Effect on Ribosome Binding | Validation Method |
|---|---|---|
| KOW domain mutations | Reduced binding to monosomes | Gradient sedimentation |
| SMR domain deletion | Dramatic reduction in collision sensing | Gradient sedimentation |
| Walker B (E416A) | Little effect on binding | Gradient sedimentation |
| H743A equivalent | Reduced ribosome splitting activity | In vivo reporter assay |
These methodologies draw from successful approaches with B. subtilis MutS2 and should be adapted for E. faecalis-specific characteristics.
Mutations in DNA repair proteins like MutS and MutL have been associated with hypermutator phenotypes in various bacterial species . For E. faecalis MutS2:
Mutation rate assessment:
Fluctuation analysis to determine spontaneous mutation frequencies
Rifampicin resistance emergence assay as a marker for mutation rate
Comparative analysis between wild-type and mutS2 variant strains
Antibiotic resistance development:
Serial passage experiments in sub-inhibitory antibiotic concentrations
Focus on antibiotics requiring specific mutations for resistance (e.g., linezolid)
Sequence analysis of target genes before and after selection
Genetic analysis of clinical isolates:
Previous research with E. faecium found specific amino acid substitutions in MutS proteins from certain lineages (e.g., CC17) . While not proven to cause hypermutator phenotypes, these variations might influence genetic stability. A similar analysis of E. faecalis MutS2 variants could reveal lineage-specific patterns relevant to antibiotic resistance development.
The SMR domain of MutS2 proteins possesses nuclease activity crucial for their function . To characterize this activity:
Substrate preparation:
Linear DNA (PCR products, restriction fragments)
Circular DNA (plasmids in supercoiled and nicked forms)
RNA substrates (in vitro transcribed, with and without secondary structures)
DNA:RNA hybrids to test substrate specificity
Nuclease assay conditions:
Buffer composition: Typically Tris-HCl (pH 7.5-8.0), MgCl₂ (5-10 mM), NaCl (50-100 mM)
Temperature range: 25-37°C
Time course: 0-60 minutes with sampling at regular intervals
Controls: Heat-inactivated enzyme, EDTA inhibition
Activity detection methods:
Gel electrophoresis (agarose for DNA, PAGE for RNA)
Fluorescence-based assays using labeled substrates
Real-time monitoring using PicoGreen or equivalent dyes
Kinetic analysis:
Determination of Km and Vmax using varied substrate concentrations
Assessment of metal ion dependence (Mg²⁺, Mn²⁺, Ca²⁺)
pH profile to determine optimum conditions
Mutational analysis:
| Substrate Type | Expected Activity | Detection Method | Control |
|---|---|---|---|
| Linear dsDNA | Moderate | Agarose gel | DNase I |
| Supercoiled plasmid | Variable (nicking) | Agarose gel | Nicking enzyme |
| RNA | Potentially high | Urea-PAGE | RNase A |
| DNA:RNA hybrid | Structure-dependent | Both gel types | RNase H |
Based on successful approaches with related organisms :
Target gene identification and analysis:
Obtain the complete sequence of E. faecalis mutS2 from reference genomes
Analyze flanking regions for designing homologous recombination
Identify unique restriction sites within the gene for insertion of selection markers
Knockout strategy:
Amplify a fragment containing the mutS2 gene (~2.5 kb) using PCR
Clone into a suitable vector (e.g., pGEM-T)
Insert an antibiotic resistance cassette (e.g., chloramphenicol acetyltransferase) at an appropriate restriction site
Transform the construct into E. faecalis via natural transformation or electroporation
Select transformants using the appropriate antibiotic
Verification methods:
PCR confirmation showing increased fragment size due to cassette insertion
Direct sequencing of the PCR fragment to confirm cassette orientation
RT-PCR to confirm absence of functional mutS2 transcript
Western blot to verify absence of MutS2 protein
Complementation:
Reintroduce wild-type mutS2 at an ectopic location to confirm phenotype specificity
Use inducible promoters for controlled expression studies
Include epitope tags for monitoring expression levels
This methodology has been successfully applied to create ΔmutS2 strains in related organisms like H. pylori and can be adapted for E. faecalis with appropriate modifications for transformation efficiency and selection markers suitable for enterococci.
Researchers may encounter conflicting data regarding MutS2 function, as illustrated by discrepancies in structural studies of B. subtilis MutS2 . A systematic approach to reconciling contradictions includes:
Methodological comparison:
Examine differences in experimental conditions (in vitro vs. in vivo)
Compare protein constructs (full-length vs. truncated, tag position)
Evaluate expression systems and purification protocols
Structural heterogeneity analysis:
Strain background effects:
Compare results across different isolates and reference strains
Consider genomic context and potential compensatory mechanisms
Evaluate growth conditions that might influence protein function
Reconciliation strategies:
Direct comparative experiments under identical conditions
Collaboration between laboratories reporting discrepancies
Meta-analysis of published data with statistical assessment
When confronted with contradictory findings about E. faecalis MutS2, researchers should consider that both sets of data may reflect different aspects of a complex, multifunctional protein. The apparently contradictory results regarding B. subtilis MutS2-ribosome interactions ultimately revealed insights about dynamic conformational states relevant to function.
To analyze MutS2 sequence variations across E. faecalis strains:
Sequence acquisition and alignment:
Collect MutS2 sequences from diverse E. faecalis isolates
Include clinical, commensal, and environmental strains
Use MUSCLE or MAFFT for multiple sequence alignment
Conservation analysis:
Calculate per-residue conservation scores
Generate sequence logos for highly variable regions
Map conservation onto structural models
Statistical tests for selection:
dN/dS ratio calculation to identify selection pressures
McDonald-Kreitman test to compare within-species polymorphism
Tajima's D to detect departures from neutral evolution
Correlation with phenotypic data:
Associate sequence clusters with antibiotic resistance profiles
Correlate specific mutations with hypermutator phenotypes
Analyze strain epidemiology in relation to MutS2 variants
| Analysis Type | Purpose | Software/Tool | Output Format |
|---|---|---|---|
| Sequence conservation | Identify constrained regions | ConSurf, Jalview | Heat maps, conservation scores |
| Selection analysis | Detect evolutionary pressure | PAML, HyPhy | dN/dS values, p-values |
| Polymorphism assessment | Identify significant variants | DnaSP, MEGA | Nucleotide diversity, haplotype analysis |
| Structure mapping | Visualize functional impact | PyMOL, UCSF Chimera | 3D models with conservation coloring |
This approach has revealed important MutS variants in E. faecium lineages (e.g., CC17) and could similarly identify functionally significant MutS2 variants in E. faecalis.
Recent findings suggest broader functions for MutS2 beyond traditional DNA metabolism . Priority areas for future investigation include:
Ribosome quality control mechanisms:
Determine if E. faecalis MutS2 recognizes and resolves stalled ribosomes
Investigate potential collaboration with other ribosome rescue factors
Assess impact on translation fidelity during stress conditions
Oxidative stress response:
Examine MutS2 regulation under oxidative conditions relevant to host-pathogen interactions
Investigate protection against oxidative DNA damage
Assess potential sensing of oxidized nucleotides
Biofilm formation and persistence:
Analyze MutS2 expression in biofilm vs. planktonic states
Compare wild-type and ΔmutS2 strains for biofilm architecture
Investigate connections to persister cell formation
Interaction with host immunity:
E. faecalis can evade immune clearance through multiple mechanisms, including suppression of pro-inflammatory responses and prevention of neutrophil extracellular trap formation . The potential contribution of MutS2 to these processes, particularly through stress response modulation, represents an important avenue for future research.
Given the emerging roles of MutS2 in stress response and potential contributions to pathogenicity, targeting this protein could offer novel antimicrobial approaches:
Inhibitor development strategies:
Structure-based design targeting the SMR nuclease domain
Allosteric inhibitors disrupting MutS2-ribosome interactions
ATPase inhibitors affecting nucleotide-dependent conformational changes
Combination therapy approaches:
MutS2 inhibitors with conventional antibiotics
Targeting MutS2 to prevent development of resistance to other drugs
Potentiation of host immune clearance mechanisms
Anti-virulence applications:
Modulation of MutS2 to reduce biofilm formation capacity
Interference with MutS2-mediated stress responses during infection
Attenuation of E. faecalis persistence within host cells
Genetic stability disruption:
Synthetic lethality approaches targeting pathways dependent on MutS2
Induction of toxic recombination intermediates in MutS2-inhibited cells
Combination with DNA-damaging agents to overwhelm repair capacity
These approaches would require detailed structural and functional characterization of E. faecalis MutS2, but could potentially address the significant clinical challenge posed by E. faecalis infections, particularly those involving biofilm formation and immune evasion .